Detalhe da pesquisa
1.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med
; 387(12): 1089-1098, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027570
2.
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J
; 44(24): 2170-2183, 2023 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220172
3.
Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.
Am Heart J
; 263: 133-140, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220822
4.
Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure.
J Am Coll Cardiol
; 82(10): 1014-1026, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37610398
5.
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial.
JACC Heart Fail
; 10(3): 184-197, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35241246